The latest hires in pharmaceutical outsourcing in this week's column.
Novella Clinical, a contract research organisation (CRO) bought by Quintiles in September last year, has named Lynne Bui senior medical director of its oncology division.
Bui has a background as a doctor in haematology-oncology, with nine years’ experience in the pharmaceutical industry, working on drug development for solid tumours and haematologic malignancies. She has led Phase I-IV clinical studies and been a drug development consultant for biologics and pharmaceutical companies in oncology, hematology and internal medicine.
Bui received her medical degree, postgraduate training in internal medicine and postgraduate fellowship in Hematology-Oncology at the University of California, Los Angeles. In 2003 she received the Pfizer Oncology Fellowship Award for Outstanding Academic Achievement in Cancer Research.
Copyright - Unless otherwise stated all contents of this web site are © 2014 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Recipharm, Catalent, INC and PRA completed eye-catching IPOs in 2014. Which firms are likely follow suit in 2015?
Catering for low value, high volume customers as well as the growing number of firms developing complex...
Clinverse, Intertek and inVentiv are among the pharma services companies announcing new staff this week.